One vaccine injection could carry many doses
Microparticles created by new 3-D fabrication method could release drugs or vaccines long after injection.
Fikile Brushett and Florence Wagner named to Chemical and Engineering News “Talented 12”
MIT affiliates recognized for their innovative approaches to energy storage and drug discovery.
New way to test antibiotics could lead to better drugs
Study finds bacterial response to drugs varies in different environments.
How cytoplasm “feels” to a cell’s components
In study that may guide drug design, researchers find organelles encounter varying levels of resistance.
Ram Sasisekharan wins Agilent Thought Leader Award
Honor recognizes bioengineer’s advance of analytical techniques for characterization of biopharmaceuticals.
STEX event showcases innovations in fitness technology and science
Entrepreneurs, researchers, and industry experts build connections at workshop.
MIT Corporation life member and biotech pioneer Henri Termeer dies at 71
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Study helps explain varying outcomes for cancer, Down Syndrome
Differences in chromosome number may underlie variation among genetically identical individuals.
MIT receives $7.5 million to enhance structural biology research
Beckman Foundation grant helps secure cryo-electron microscopy at MIT.nano facility.
Progress toward a Zika vaccine
Researchers program RNA nanoparticles that could protect against the virus.
New technology offers fast peptide synthesis
Automated manufacturing could make it easier to develop and test new peptide drugs.
MIT undertakes Grand Challenge for innovation in global vaccine manufacturing
Bill and Melinda Gates Foundation awards MIT, University College London, and University of Kansas $17.6M for development and production of low-cost vaccines.
Coming together for immuno-oncology
Takeda's $1 million gift to the MIT Koch Institute will advance research into how the immune system affects cancer.
Microbial manufacturing
Engineered bacteria produce rare and commercially useful compounds in large quantities.
Catalyst adds fluorine-containing groups to make new compounds
Introducing such groups to potential drugs could make them more effective.